Clin2
NCT04715542Possibly a fitNot yet recruiting

Homeopathic medicine to prevent nerve damage from paclitaxel

Chemotherapy Induced Peripheral Neuropathy (CIPN)

Part of Brain & nervous system, Cancer clinical trials.

This trial tests whether a homeopathic medicine called Stibium Metallicum Praeparatum D6 can reduce nerve damage (neuropathy) caused by paclitaxel chemotherapy. If you are starting paclitaxel for breast or gynecologic cancer, this treatment might help prevent or lessen tingling, numbness, or pain in your hands and feet.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
86 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older
  • You have breast, ovarian, or another gynecologic cancer
  • You are about to start paclitaxel chemotherapy (weekly or every 3 weeks) for 12 or 18 weeks
  • You do not already have nerve damage (neuropathy) in your hands or feet
  • You have not had chemotherapy with taxanes or other nerve-damaging drugs before
  • You are not taking medications that can cause nerve damage
  • You are not pregnant or breastfeeding, and if you could become pregnant, you use reliable birth control
  • You do not have depression, epilepsy, or a milk protein allergy
  • You can read, write, and speak German

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07780955Recruiting
Cold therapy for nerve damage from paclitaxel chemotherapy

This study tests whether wearing cold gloves and socks during paclitaxel chemotherapy can prevent or reduce nerve damage in the hands and feet, a common side effect. If you are getting weekly paclitaxel for breast cancer, this might help keep your hands and feet more comfortable.

Bolzano, Bolzano
NCT06994507Recruiting· Phase 3
GM1 to prevent nerve damage from breast cancer chemo

This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.

Beijing
NCT06811220Not yet recruiting· Phase 3
Citrus supplements to prevent nerve pain from paclitaxel

This trial tests whether taking two natural citrus compounds (hesperidin and diosmin) as daily pills can help prevent or reduce nerve damage (tingling, numbness, or pain in hands/feet) caused by the chemotherapy drug paclitaxel. If it works, it could make treatment more comfortable and improve your quality of life during breast cancer therapy.

NCT05928429Recruiting
Cold treatment to prevent nerve pain from weekly paclitaxel

This trial tests whether cryotherapy (cooling the hands/feet during chemo) can prevent or lessen nerve pain caused by paclitaxel in people with early breast cancer. It may help you stay more comfortable and function better during treatment.

Copenhagen
NCT06430814Recruiting
Blood test to predict nerve damage from paclitaxel

This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.

Odense
NCT07504770Not yet recruiting
Surgical glove compression to prevent nerve damage from paclitaxel

This trial tests whether wearing surgical gloves during paclitaxel chemotherapy can reduce nerve damage (neuropathy) in the hands. If it works, patients may experience less tingling, numbness, or pain in their hands.

Konya, Meram

Hear when a new Chemotherapy Induced Peripheral Neuropathy (CIPN) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.